跳至主要内容
临床试验/NCT03720353
NCT03720353已完成1 期

Pharmacological Intervention for Symptomatic Snoring

Brigham and Women's Hospital1 个研究点 分布在 1 个国家目标入组 27 人开始时间: 2018年12月17日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
27
试验地点
1
主要终点
Snoring intensity

研究概览

简要总结

Currently, there is no pharmacological intervention capable of maintaining airway patency for the treatment of snoring and airflow limitation during sleep. Here we study the effect of pharmacological stimulation of the pharyngeal muscles on snoring severity, in a randomized quadruple-blind, crossover study.

详细描述

Two active interventions are being studied and compared against placebo. Participants will therefore be randomized to one of six possible sequences. Washout periods will be 1 week.

Effects of interventions on outcomes will be assessed using mixed effect model analyses: we will quantify the effect of active treatment 1 (referenced to placebo), the effect of active treatment 2 (referenced to placebo), adjusting for effects of time (period number), carryover effects, and baseline values (fixed effects). Participants are considered random effects.

Primary outcome is based on significance of active intervention 1 versus placebo.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 79 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Active H

Active Comparator

Participants will take SAS2094AL and SAS2094BH for 3 days, then SAS2094AH and SAS2094BH for 7 days.

干预措施: SAS2094AH and SAS2094BH (Drug)

Active L

Active Comparator

Participants will take SAS2094AL and SAS2094BL for 10 days

干预措施: SAS2094AL and SAS2094BL (Drug)

Placebo

Placebo Comparator

Participants will take placebo for 10 days.

干预措施: Placebo (Drug)

结局指标

主要结局

Snoring intensity

时间窗: 1 week

mean tracheal snoring sound intensity (tracheal microphone), decibels

次要结局

  • Stage 1 Sleep(1 week)
  • Arousal index(1 week)
  • Visual-Analog Scale for Treatment Satisfaction(1 week)
  • Epworth Sleepiness Scale(1 week)
  • Visual-Analog Scale for Sleep Quality(1 week)
  • Flow-limitation severity(1 week)
  • Mean oxygen saturation(1 week)
  • Snoring frequency(1 week)
  • Snoring Self-Evaluation Scale(1 week)
  • Snoring Bed-Partner Evaluation Scale(1 week)
  • Flow-limitation frequency(1 week)
  • Functional Outcomes of Sleep Questionnaire(1 week)
  • "Would you keep using this medication?"(1 week)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Scott Aaron Sands

Assistant Professor of Medicine

Brigham and Women's Hospital

研究点 (1)

Loading locations...

相似试验